- Home
- / ImmunityBio
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
ImmunityBio financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$5.6
2024-10-29
Market Capitalization
$4.3 B
2024-10-29
Revenue
$622 K
FY, 2023
CreditSafe Score
?
Score changed on Jan 18, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 44.0K | 45.0K | 47.0K | 43.0K | 111.0K | 934.0K | 240.0K | 622.0K |
| Revenue growth, % | 2.3% | 4.4% | ||||||
| General and administrative expense | 95.4M | 57.1M | 42.7M | 18.1M | 27.3M | 135.3M | 102.7M | 129.6M |
| Operating expense total | 124.5M | 99.2M | 98.4M | 67.9M | 91.7M | 350.9M | ||
| EBIT | (124.5M) | (99.1M) | (98.4M) | (67.8M) | (91.6M) | (330.3M) | (351.3M) | (362.2M) |
| EBIT margin, % | -282954.5% | -220266.7% | -209338.3% | -157690.7% | -82545.9% | -146374.2% | ||
| Investment income | 1.6M | 366.0K | (803.0K) | (12.1M) | (7.5M) | |||
| Interest income | 863.0K | |||||||
| Interest expense | 66.0K | 618.0K | 433.0K | 129.2M | ||||
| Pre tax profit | (121.4M) | (96.9M) | (96.7M) | (65.9M) | (92.4M) | (349.8M) | (417.3M) | (583.9M) |
| Income tax expense | (503.0K) | (97.0K) | 5.0K | 9.0K | 34.0K | (40.0K) | ||
| Net Income | (120.8M) | (96.4M) | (96.2M) | (65.8M) | (92.4M) | (349.8M) | (417.3M) | (583.9M) |
| EPS | (1.0) | (1.0) |